Peripheral GABA_A receptor-mediated signaling facilitates persistent inflammatory hypersensitivity

Area of Science:

• Neuroscience
• Pain Research
• Pharmacology

Background:

• In the peripheral nervous system (PNS), GABA_A receptors (GABA_AR) activation is typically excitatory due to high intracellular chloride.
• While acute inflammatory pain is exacerbated by GABAergic agents, their role in persistent inflammatory pain is not well understood.

Purpose of the Study:

• To investigate the role of peripheral GABA_AR and endogenous GABA in the development of persistent inflammatory pain.
• To explore potential therapeutic targets for inflammatory pain based on GABAergic signaling.

Main Methods:

• Utilized a Complete Freund's Adjuvant (CFA)-induced persistent inflammatory pain mouse model.
• Administered GABA_AR antagonists (picrotoxin, bicuculline) and anti-GABA antibodies intraplantarly.
• Assessed nociceptive behaviors and mechanical hypersensitivity.
• Quantified Gad1 and Gad2 mRNA expression via RT-qPCR.
• Administered a GABA_AR positive allosteric modulator (3α,5α-THP).

Main Results:

• GABA_AR antagonists significantly inhibited spontaneous nociceptive behaviors and mechanical hypersensitivity in CFA-injected mice.
• Anti-GABA antibodies reversed CFA-induced mechanical hypersensitivity.
• Glutamate decarboxylase (GAD) mRNA expression was upregulated in CFA-inflamed paws.
• GABA_AR positive allosteric modulator induced mechanical hypersensitivity in naïve mice.

Conclusions:

• Peripheral GABA_AR and endogenous GABA potentiate CFA-induced persistent inflammatory hypersensitivity.
• These findings suggest that peripheral GABAergic signaling is a viable therapeutic target for inflammatory pain management.